Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Mid-Size Pharmaceuticals Industry?

The market for mid-sized pharmaceuticals has seen robust growth in the past few years. The market value is projected to increase from $718.71 billion in 2024 to $760.71 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.8%. The historical growth can be linked to the expansion of the generic drug market, the expiry of patents on major drugs, measures taken to contain healthcare costs, growth in biotechnology, and regulatory modifications supporting innovation.

The mid-sized pharmaceuticals sector is projected to witness considerable expansion in the coming years, as it is set to reach $983.81 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during the forecast period can be linked to the increasing shift towards value-based care systems, efficient regulatory routes, improved health consciousness, patient empowerment, and a rising demand for generics and biosimilars, as well as the advent of digital therapeutics. The forecast period will also likely see emerging trends such as heightened emphasis on patient-focused approaches, the integration of artificial intelligence (AI), strategies for global market growth, initiatives for ecological sustainability, telemedicine and remote patient surveillance.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12045&type=smp

#Which Factors Are Currently Driving The Growth Of The Mid-Size Pharmaceuticals Market?

The escalating occurrence of chronic illnesses is projected to drive the expansion of the mid-size pharmaceuticals market in the future. Chronic diseases, otherwise referred to as non-communicable diseases, are enduring healthcare conditions demanding constant management and therapy which triggers a high requirement for medicines. Techniques of mass spectrometry are utilized for the detection, quantification, and assessment of biomarkers and metabolites related to chronic illnesses. An upsurge in the frequency of chronic illnesses will boost the growth of the mid-size pharmaceuticals market. For example, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported in September 2023 that there had been 41 million deaths worldwide, corresponding to 74% of all those caused by non-communicable or chronic diseases every year. As a consequence, the rising prevalence of chronic diseases is contributing to the growth of the mid-size pharmaceuticals market.

How Is The Global Mid-Size Pharmaceuticals Market Structured In Terms Of Segments?

The mid-size pharmaceuticals market covered in this report is segmented –

1) By Drug Development Type: In-House, Outsource

2) By Type: Prescription, Over The Counter

3) By Formulation: Tablets, Capsules, Injectables, Sprays, Other Formulations

4) By Application: Cardiovascular Diseases, Pain Management, Diabetes, Cancer, Other Conditions

Subsegments:

1) By In-House: Research And Development (R&D) Departments, Clinical Trials Management

2) By Outsource: Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs)

What Trends Are Currently Influencing Growth In The Mid-Size Pharmaceuticals Market?

The surge in technological advancements is a prominent trend gaining traction in the medium-sized pharmaceuticals sector. Leading firms in the medium-sized pharmaceuticals market are leveraging technology to maintain their market standing. For example, in May 2023, Google Cloud, a US-based set of cloud computing services provided by Google, introduced AI-based tools to expedite drug discovery and precision medicine. One such tool, the Target and Lead Identification Suite, aids firms in predicting and understanding the structure of proteins – a critical element in drug research. Another instrumental tool, the Multiomics Suite, will facilitate researchers in managing, scrutinizing, and sharing considerable quantities of genetic data.

Who Are The Main Participants Shaping The Mid-Size Pharmaceuticals Market Landscape?

Major companies operating in the mid-size pharmaceuticals market include Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Alexion Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Wuxi AppTec co. Ltd., Les Laboratoires Servier S.A., Hospira Inc., Perrigo Co Plc, Aurobindo Pharma Lmited., Cipla Limited, Hikma Pharmaceuticals, Endo International plc, Taisho Pharmaceutical Holdings Co. Ltd., BioMarin Pharmaceutical Inc., Mallinckrodt Plc, Exelixis Inc., Mylan Pharmaceuticals Inc., Neurocrine Biosciences Inc., Kyowa Kirin Co. Ltd., Emergent BioSolutions Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/mid-size-pharmaceuticals-global-market-report

Which Region Currently Holds The Largest Share In The Mid-Size Pharmaceuticals Market?

North America was the largest region in the mid-size pharmaceutical market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mid-size pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12045&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model